KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Other Non-Current Assets (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Other Non-Current Assets readings, the most recent being $1.8 billion for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 286.64% to $1.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.8 billion, a 286.64% increase, with the full-year FY2025 number at $405.0 million, down 77.13% from a year prior.
  • Other Non-Current Assets hit $1.8 billion in Q1 2026 for Teva Pharmaceutical Industries, up from $405.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.8 billion in Q3 2025 to a low of $2.0 million in Q3 2024.
  • Median Other Non-Current Assets over the past 5 years was $450.0 million (2023), compared with a mean of $544.4 million.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 98.06% in 2022 and later soared 90350.0% in 2025.
  • Teva Pharmaceutical Industries' Other Non-Current Assets stood at $10.0 million in 2022, then surged by 4600.0% to $470.0 million in 2023, then surged by 276.81% to $1.8 billion in 2024, then crashed by 77.13% to $405.0 million in 2025, then surged by 342.96% to $1.8 billion in 2026.
  • The last three reported values for Other Non-Current Assets were $1.8 billion (Q1 2026), $405.0 million (Q4 2025), and $1.8 billion (Q3 2025) per Business Quant data.